E-Articles - Health and Fitness

Carpal Tunnel Syndrome is a painful condition that is characterized by symptoms such as pain, swelling, numbness, tingling, paresthesia (pins and needles) and loss of

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

strength and coordination in the thumb, index, middle and sometimes one-half of the ring finger. Not all of the symptoms or fingers have to be affected simultaneous

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

y as symptoms often vary and may move around. (Symptoms present in the ring and little finger are not carpal tunnel syndrome and instead are related to ulnar nerve e

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

trapment in disorders like Guyon’s Syndrome and Cubital Tunnel Syndrome.)

Carpal Tunnel Syndrome is the most common nerve entrapment disorder in the past decade and

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s generally caused by muscle strength and length imbalance that exists between the flexor muscles that close the hand and the extensor muscles that open the hand, res

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ulting in excessive pressure on the median nerve. Surgery is one option for treating this disabling condition; however, it remains a controversial choice and it is i

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

portant to fully understand the risks and benefits involved.

There are many invasive and non-invasive treatments for carpal tunnel syndrome including medication, exe

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

cise, wrist splinting, and corticosteroid nerve injections. Surgery is by far the most invasive procedure and it merits careful forethought as a majority of those un

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ergoing the knife may obtain some relief, long-term relief has a very poor success rate. In contrast, the vast majority of patients fare better with conservative tre

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

atment and it is estimated that less than 1/3 require surgical intervention. Indeed, surgery is only recommended when there is persistent, debilitating pain, deterio

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ated grip or grasping, muscle flattening and all other conservative methods have been tried.

There are multiple forms of surgery for Carpal Tunnel Syndrome including

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

open hand surgery and endoscopic surgery, a less invasive incision through the muscle in the palm. Symptoms such as pain and numbness usually begin to improve in abo

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

t 18-days with endoscopic release and about 38-days with open release surgery. Muscle coordination, control, and strength may initially worsen following surgery, and

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

a return to pre-operative status may take several months for some people, depending on the procedure performed, age, severity of symptoms and length of injury presen

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

prior to surgery. Significant improvement to pre-injury status may take as much as two years to achieve, if it comes at all according to the following carpal tunnel

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

surgery statistics:

· ONLY 23% of all Carpal Tunnel Syndrome patients returned to their previous professions following surgery, according to the Bureau of Labor & St

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

tistics and the National Institute for Occupational Safety & Health (1997-2000 Statistics).

· Carpal Tunnel Surgery has about a 57% failure rate following patients f

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

rom 1-day to 6-years. At least one of the following symptoms re-occurred during this time: Pain, Numbness, Tingling sensations. Source: Nancollas, et al, 1995. J. Han

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

Surgery.

The complications associated with surgery as well as the timeline to substantial recovery make it a last choice resort for most patients. Thankfully, ther

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

are numerous effective treatment alternatives that are much less invasive and provide more immediate and long-term relief for those disable by Carpal Tunnel Syndrome

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/262352/e-article-Carpal-Tunnel-Syndrome-Surgery--Is-it-Effective.html">Carpal Tunnel Syndrome Surgery - Is it Effective?</a>

BB link (for phorums):
[url=http://www.e-article.org.ua/article/262352/e-article-Carpal-Tunnel-Syndrome-Surgery--Is-it-Effective.html]Carpal Tunnel Syndrome Surgery - Is it Effective?[/url]

The mortgage industry is growing, with every second person looking for a loan to purchase a home or vehicle. Some mortgage brokers have very large businesses and many contacts, all over the city, state or country. So these brokers usually employ individuals or sign contracts with the loan originators, to expand their business. The company that gives their franchise to another company is referred to as the mortgage originator and the company that takes the franchise, is called a mortgage net branch. In the United States, this kind of agreement is becoming popular because it is beneficial to both the mortgage originator and mortgage net branch. The mortgage originators expand their business, while the mortgage net branches get their brokerages and secure their business.

How can you tell if a real estate agent is up to date on technology? Read my article

Tags

Links

E-Articles - Carpal Tunnel Syndrome Surgery - Is it Effective?

Related Articles: